Host antiviral defense and viral replication machinery

Host antiviral defense and viral replication machinery refers to the complex interplay between a host organism's immune system and the biochemical processes a virus uses to reproduce. The host defense involves innate immune sensors like Toll-like receptors (TLRs) and RIG-I-like receptors (RLRs) that detect viral components and trigger the production of interferons and pro-inflammatory cytokines (Kawai & Akira, 2006). Conversely, the viral replication machinery includes viral-encoded enzymes such as RNA-dependent RNA polymerases, proteases, and integrases, as well as hijacked host factors like ribosomes and chaperones (Garcia-Blanco et al., 2004). Therapeutic intervention in this area focuses on either bolstering the host's ability to clear the infection or directly disrupting the viral life cycle (De Clercq & Li, 2016). Because this term encompasses a vast array of distinct proteins and pathways rather than a single molecular entity, it is classified as a biological system rather than a discrete therapeutic target. Understanding these interactions is critical for developing broad-spectrum antivirals and vaccines (Nature Reviews Drug Discovery, 2020).

Other names

Host-virus interfaceViral replication cycleAntiviral innate immunityHost-pathogen interaction

Direct inhibition of viral replication enzymes (e.g., polymerases, proteases) or modulation of host innate immune signaling pathways (e.g., interferon induction).